Literature DB >> 19667320

Subclinical cerebrovascular disease in mild cognitive impairment.

J A Luchsinger1, A M Brickman, C Reitz, S J Cho, N Schupf, J J Manly, M X Tang, S A Small, R Mayeux, C DeCarli, T R Brown.   

Abstract

BACKGROUND: Cerebrovascular disease (CVD) may contribute to mild cognitive impairment (MCI). We sought to determine the relation of white matter hyperintensity (WMH) volume and infarcts in brain MRI to MCI in a community-based sample.
METHODS: A total of 679 elderly persons without dementia underwent brain MRI. WMH and infarcts were quantified using research methods. WMH was adjusted for total cranial volume. The Petersen criteria were used to define MCI. MCI was further subclassified into amnestic and non-amnestic. We used logistic regression to relate WMH and infarcts to prevalent MCI.
RESULTS: WMH were associated with amnestic MCI (odds ratio [OR] = 1.9; 95% confidence interval [CI] 1.1, 3.4) but not non-amnestic MCI (OR = 1.2; 95% CI 0.4, 1.6) after adjusting for age, gender, ethnic group, education, and APOE-epsilon4. Infarcts were more strongly associated with non-amnestic MCI (OR = 2.7; 95% CI 1.5, 4.8) than amnestic MCI (OR = 1.4; 95% CI 0.9, 2.3). In secondary analyses using continuous cognitive scores as outcomes, WMH, but not infarcts, were related to memory, while infarcts were more strongly related with non-amnestic domains.
CONCLUSION: White matter hyperintensity (WMH) is more strongly related to amnestic mild cognitive impairment (MCI). Infarcts are more strongly related to non-amnestic MCI. The nature of WMH in amnestic MCI requires further study.

Entities:  

Mesh:

Year:  2009        PMID: 19667320      PMCID: PMC2727144          DOI: 10.1212/WNL.0b013e3181b1636a

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  38 in total

1.  Aggregation of vascular risk factors and risk of incident Alzheimer disease.

Authors:  J A Luchsinger; C Reitz; L S Honig; M X Tang; Steven Shea; R Mayeux
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

2.  Does the white matter matter in Alzheimer disease and cerebral amyloid angiopathy?

Authors:  Jin-Moo Lee; Hugh S Markus
Journal:  Neurology       Date:  2006-01-10       Impact factor: 9.910

3.  Clinical and neuropsychological features associated with structural imaging patterns in patients with mild cognitive impairment.

Authors:  Roberta Rossi; Cristina Geroldi; Lorena Bresciani; Cristina Testa; Giuliano Binetti; Orazio Zanetti; Giovanni B Frisoni
Journal:  Dement Geriatr Cogn Disord       Date:  2007-01-12       Impact factor: 2.959

4.  Regional quantification of white matter hyperintensity in normal aging, mild cognitive impairment, and Alzheimer's disease.

Authors:  Ya-Fang Chen; Huali Wang; Yong Chu; Yung-Chien Huang; Min-Ying Su
Journal:  Dement Geriatr Cogn Disord       Date:  2006-07-28       Impact factor: 2.959

5.  Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD.

Authors:  M Yoshita; E Fletcher; D Harvey; M Ortega; O Martinez; D M Mungas; B R Reed; C S DeCarli
Journal:  Neurology       Date:  2006-12-26       Impact factor: 9.910

6.  Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy.

Authors:  Y W Chen; M E Gurol; J Rosand; A Viswanathan; S M Rakich; T R Groover; S M Greenberg; E E Smith
Journal:  Neurology       Date:  2006-07-11       Impact factor: 9.910

7.  Measures of brain morphology and infarction in the framingham heart study: establishing what is normal.

Authors:  Charles DeCarli; Joseph Massaro; Danielle Harvey; John Hald; Mats Tullberg; Rhoda Au; Alexa Beiser; Ralph D'Agostino; Philip A Wolf
Journal:  Neurobiol Aging       Date:  2005-04       Impact factor: 4.673

Review 8.  Predictors of reversible mild cognitive impairment after stroke: a 2-year follow-up study.

Authors:  S M C Rasquin; J Lodder; F R J Verhey
Journal:  J Neurol Sci       Date:  2004-12-28       Impact factor: 3.181

9.  Association between mild vascular cognitive impairment and impaired activities of daily living in older stroke survivors without dementia.

Authors:  Sally Stephens; Rose Anne Kenny; Elise Rowan; Raj N Kalaria; Michael Bradbury; Ruth Pearce; Keith Wesnes; Clive G Ballard
Journal:  J Am Geriatr Soc       Date:  2005-01       Impact factor: 5.562

10.  Clinical determinants of dementia and mild cognitive impairment following ischaemic stroke: the Sydney Stroke Study.

Authors:  P S Sachdev; H Brodaty; M J Valenzuela; L Lorentz; J C L Looi; K Berman; A Ross; W Wen; A S Zagami
Journal:  Dement Geriatr Cogn Disord       Date:  2006-02-10       Impact factor: 2.959

View more
  45 in total

Review 1.  Cognitive impairment and risk of future stroke: a systematic review and meta-analysis.

Authors:  Meng Lee; Jeffrey L Saver; Keun-Sik Hong; Yi-Ling Wu; Hsing-Cheng Liu; Neal M Rao; Bruce Ovbiagele
Journal:  CMAJ       Date:  2014-08-25       Impact factor: 8.262

2.  Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence.

Authors:  Adam M Brickman; Laura B Zahodne; Vanessa A Guzman; Atul Narkhede; Irene B Meier; Erica Y Griffith; Frank A Provenzano; Nicole Schupf; Jennifer J Manly; Yaakov Stern; José A Luchsinger; Richard Mayeux
Journal:  Neurobiol Aging       Date:  2014-07-21       Impact factor: 4.673

3.  Type 2 diabetes and late-onset Alzheimer's disease.

Authors:  D Cheng; J Noble; M X Tang; N Schupf; R Mayeux; J A Luchsinger
Journal:  Dement Geriatr Cogn Disord       Date:  2011-07-15       Impact factor: 2.959

Review 4.  Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.

Authors:  Adam M Brickman
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

5.  Improved diabetes control in the elderly delays global cognitive decline.

Authors:  J A Luchsinger; W Palmas; J A Teresi; S Silver; J Kong; J P Eimicke; R S Weinstock; S Shea
Journal:  J Nutr Health Aging       Date:  2011-06       Impact factor: 4.075

6.  Quantitative approaches for assessment of white matter hyperintensities in elderly populations.

Authors:  Adam M Brickman; Joel R Sneed; Frank A Provenzano; Ernst Garcon; Lauren Johnert; Jordan Muraskin; Lok-Kin Yeung; Molly E Zimmerman; Steven P Roose
Journal:  Psychiatry Res       Date:  2011-06-16       Impact factor: 3.222

Review 7.  Clinically asymptomatic vascular brain injury: a potent cause of cognitive impairment among older individuals.

Authors:  Charles DeCarli
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

8.  Course and etiology of dysexecutive MCI in a community sample.

Authors:  Edward D Huey; Jennifer J Manly; Ming-X Tang; Nicole Schupf; Adam M Brickman; Masood Manoochehri; Jesse Mez; Charles DeCarli; Davangere P Devanand; Richard Mayeux
Journal:  Alzheimers Dement       Date:  2013-02-27       Impact factor: 21.566

9.  White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?

Authors:  Frank A Provenzano; Jordan Muraskin; Giuseppe Tosto; Atul Narkhede; Ben T Wasserman; Erica Y Griffith; Vanessa A Guzman; Irene B Meier; Molly E Zimmerman; Adam M Brickman
Journal:  JAMA Neurol       Date:  2013-04       Impact factor: 18.302

10.  Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter?

Authors:  Adam M Brickman; Jordan Muraskin; Molly E Zimmerman
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.